ALS EBITDA
Cos'è EBITDA di ALS?
EBITDA di ALS Limited è AUD$443.800M
Qual è la definizione di EBITDA?
L'EBITDA è il reddito di una società prima di interessi, imposte, deprezzamenti e ammortamenti ed è una misura contabile calcolata utilizzando gli utili netti di una società, prima che vengano sottratti interessi passivi, imposte, ammortamenti e ammortamenti come proxy della redditività corrente di un'azienda.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA di aziende nel Industrials settore su ASX rispetto a ALS
Cosa fa ALS?
ALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, North Africa, and the Americas. The company operates through three segments: Commodities, Life Sciences, and Industrial. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies in geochemistry, metallurgy, inspection, and coal quality areas. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides coal sampling, analysis and certification, formation evaluation, and related analytical testing services. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment also provides analytical testing data to assist consulting and engineering firms, industries, and governments. The Industrial segment offers diagnostic testing and engineering solutions for the energy, resources, transportation, and infrastructure sectors. This segment serves asset owners, operators, constructors, and equipment manufacturers in the power, petrochemical, mining, minerals processing, water, infrastructure, and transportation industries. The company was formerly known as Campbell Brothers Limited and changed its name to ALS Limited in August 2012. ALS Limited was founded in 1863 and is headquartered in Stafford, Australia.
Aziende con ebitda simili a ALS
- Mangalam Drugs & Organics ha EBITDA di ₨442.240M
- Ultra Petroleum ha EBITDA di $442.503M
- Ultra Petroleum ha EBITDA di $442.503M
- Wendt (India) ha EBITDA di ₨442.930M
- Accuracy Shipping ha EBITDA di ₨442.982M
- Dawnrays Pharmaceutical () ha EBITDA di ¥443.042M
- ALS ha EBITDA di AUD$443.800M
- Luoyang Glass ha EBITDA di ¥443.817M
- Acrysil ha EBITDA di ₨443.957M
- Armstrong World Industries ha EBITDA di $444.000M
- Sopra Steria SA ha EBITDA di €444.800M
- Dhunseri Investments ha EBITDA di ₨444.867M
- Kokuyo Camlin ha EBITDA di ₨444.942M